Comparison

Terazosin HCl

Item no. V2587-250mg
Manufacturer InvivoChem LLC
CASRN 63074-08-8
Amount 250 mg
Quantity options 100 mg 1 g 2 g 500 mg 50 mg
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V2587CAS #:63074-08-8Purity >=98%

Description: Terazosin is a potent and selective alpha1-adrenoceptor antagonist which is used for treatment of symptoms of an enlarged prostate (BPH- benign prostatic hyperplasia). Terazosin induces cytotoxicity in PC-3 and human benign prostatic cells with an IC50 of more than 100 uM. Terazosin also effectively inhibited vascular endothelial growth factor induced proliferation and tube formation in cultured human umbilical vein endothelial cells (IC50 9.9 and 6.8 uM, respectively).

References: Neuroscience. 1999; 94(4):1245-52; J Urol. 2003 Feb; 169(2):724-9.

Related CAS#: 63074-08-8 ( Terazocin Hydrochloride); 70024-40-7 (Terazosin Hydrochloride dihydrate); 109351-33-9 (S-Terazosin); 109351-34-0 (R-Terazosin)

Molecular Weight (MW)
423.9
Formula
C19H26ClN5O4
Related CAS No.
63590-64-7 (free base);
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Solubility (In vitro)
DMSO: 10 mM
Water: N/A
Ethanol: N/A
Chemical Name
(4-(4-amino-6, 7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanone
Synonyms
Vasocard; Hyprin; A-45975; A 45975; A45975

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 250 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close